☰ Navigation Tabs
SARS-CoV-2 spike in complex with neutralizing antibody NIV-8 (state 2)
Starting Model(s) Initial Refinement Model(s) Type Source Accession Code Details experimental model PDB 6YYB
Refinement RMS Deviations Key Refinement Restraint Deviation f_dihedral_angle_d 4.1108 f_angle_d 0.4719 f_chiral_restr 0.0427 f_plane_restr 0.0043 f_bond_d 0.0019
Sample SARS-CoV-2 spike glycoprotein in complex with NIV-8 Sample Components SARS-CoV-2 spike glycoprotein NIV-8 Fab
Specimen Preparation Sample Aggregation State PARTICLE Vitrification Instrument FEI VITROBOT MARK IV Cryogen Name ETHANE Sample Vitrification Details blotting time 5 s and blotting force 5.
3D Reconstruction Reconstruction Method SINGLE PARTICLE Number of Particles 13430 Reported Resolution (Å) 3.3 Resolution Method FSC 0.143 CUT-OFF Other Details Refinement Type Symmetry Type POINT Point Symmetry C1
Map-Model Fitting and Refinement Id 1 (6YYB) Refinement Space REAL Refinement Protocol RIGID BODY FIT Refinement Target Overall B Value Fitting Procedure Details
Data Acquisition Detector Type GATAN K3 BIOQUANTUM (6k x 4k) Electron Dose (electrons/Å**2) 57
Imaging Experiment 1 Date of Experiment Temperature (Kelvin) Microscope Model TFS KRIOS Minimum Defocus (nm) 1000 Maximum Defocus (nm) 2000 Minimum Tilt Angle (degrees) Maximum Tilt Angle (degrees) Nominal CS 2.7 Imaging Mode BRIGHT FIELD Specimen Holder Model FEI TITAN KRIOS AUTOGRID HOLDER Nominal Magnification 130000 Calibrated Magnification Source FIELD EMISSION GUN Acceleration Voltage (kV) 300 Imaging Details
EM Software Task Software Package Version PARTICLE SELECTION cryoSPARC 3.3.1 IMAGE ACQUISITION EPU CTF CORRECTION cryoSPARC 3.3.1 MODEL FITTING UCSF Chimera INITIAL EULER ASSIGNMENT cryoSPARC 3.3.1 FINAL EULER ASSIGNMENT cryoSPARC 3.3.1 CLASSIFICATION cryoSPARC RECONSTRUCTION cryoSPARC 3.3.1 MODEL REFINEMENT PHENIX
Image Processing CTF Correction Type CTF Correction Details Number of Particles Selected Particle Selection Details PHASE FLIPPING AND AMPLITUDE CORRECTION 206354